Skip to content

Comparison of Laminaria and Misoprostol for Cervical Preparation Before Second Trimester Surgical Abortion

Randomized Controlled Study: Comparison of Laminaria and Misoprostol for Cervical Preparation Before Second Trimester Surgical Abortion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01678703
Enrollment
84
Registered
2012-09-05
Start date
2007-11-30
Completion date
2010-06-30
Last updated
2012-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induced; Abortion, Nonmedical

Keywords

late abortion, laminaria, Misoprostol, Cervical preparation

Brief summary

This study compares the effectiveness of cervical preparation before second trimester abortion using laminaria versus vaginal Misoprostol. The investigators hypothesize that medical preparation of the cervix with vaginal Misoprostol is superior to mechanical preparation using laminaria. The investigators believe that medical preparation makes the procedure easier to perform, equally safe, without addition of pain or discomfort.

Detailed description

This is a prospective randomized study. The aim of the study is to compare preparation of the cervix before surgical abortion with laminaria and misoprostol. Primary outcome measures will include: Initial cervical opening and the need for further dilatation at the procedure Procedure duration Difficulty score performing the abortion Complications during and after the procedure Assessment of pain, using VAS scale, and the need for analgesia before and after the procedure

Interventions

DEVICELaminaria, MedGyn Products, Inc. USA.

Insertion of Hygroscopic laminarias into the cervical canal for preparation prior to late surgical abortion. The number of laminarias is according to the cervical compliance.

DRUGMisoprostol

Cervical preparation with vaginal Misoprostol 600 mcg overnight the day before the abortion

Sponsors

Wolfson Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant patients with a viable singleton * Pregnancy 14-20 weeks of gestation * Admitted for termination of pregnancy

Exclusion criteria

* Contraindication for administration of Misoprostol * Patients with more than one previous cesarean section scar * Patients with impaired coagulation * Significant pulmonary or cardiac disease * Non viable pregnancy * Placenta accreta or previa by ultrasound

Design outcomes

Primary

MeasureTime frameDescription
Initial cervical opening and the need for further dilatation at the start of the procedure8-12 hours after insersion of laminaria or MisoprostolThe surgical abortion will be performed 8-12 hours after the insertion of laminaria, or after vaginal application of Misoprostol

Secondary

MeasureTime frameDescription
pain score during cervical preparation and after the procedureat the time of the insertion, immediately before the abortion and immediately upon recovery from anesthesiaThe pain score will be accessed immediately after the insertion of the laminaria or the vaginal Misoprostol. Pain score will be recorded again right before performing the abortion and will address the 8-12 hours elapsed from the insertion. Another assessment of pain will be recorded immediately after the abortion following recovery from general anesthesia

Other

MeasureTime frameDescription
The degree of difficulty to accomplish the abortionat the time of performing the surgical abortionThe difficulty score will be recorded by the surgeon at the operating room immediately upon completion of the procedure.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026